Event Participants
Executives 4
Saurabh Dwivedi (CVP Finance & Strategy), Sandeep Kalra (CEO), Vinit Teredesai (CFO), Jaideep Dhok (COO Technology)
Analysts 9
Aditi Patel, Dipesh Mehta, Karan Upadhyay, Nitin Padmanabhan, Raghavendra C, Ravi Menon (Macquarie), Rishi Jhunjhunwala, Sandeep Shah, Vibhor Singhal
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue (USD) | $452.4M | +3.8% QoQ, +16.1% YoY; 25th consecutive quarter of sequential growth; CC growth +4.1% QoQ, +16.5% YoY |
| Revenue (INR) | ₹43,032.3M | +6.1% QoQ, +29.1% YoY; rupee depreciation aided INR growth |
| EBIT | ₹6,868.8M | +32.7% YoY; margin 16.0%, +50bps YoY, -30bps QoQ |
| EBIT Margin | 16.0% | -30bps QoQ: lower utilization (-60bps), AI tool investments net (-20bps); offset by forex (+30bps), lower doubtful debt provisions (+20bps) |
| PAT | ₹4,830.4M | -8.7% QoQ, +13.7% YoY; QoQ decline due to forex loss of ₹1,052.7M |
| PAT Margin | 11.2% | Lower than prior quarter due to forex losses; EPS ₹30.90 (+11.3% YoY) |
| Total Contract Value (TCV) | $1.146B | Highest ever quarterly TCV; includes $650M+ strategic services agreement over 6.5 years with global tech leader |
| ACV - Total Bookings | $536.8M | New bookings ACV contributed $386M |
| Headcount | 28,640 | +1,138 QoQ; proactive hiring to support large deal ramp-up |
| Utilization | 86.5% | -150bps QoQ reflecting proactive hiring for large deal ramp-up |
| Attrition (TTM) | 12.3% | Down from 13% in prior quarter; within comfortable range of 12%-15% |
| Billed DSO | 61 days | +8 days QoQ; unbilled DSO 25 days (-2 days QoQ) |
| OCF-to-PAT | 24.2% | Delayed collections ($23M) and tax refunds ($10M) skewed quarter; adjusted OCF-to-PAT 83.2%; TTM 76.2% |
| Cash & Investments | ₹27,044.3M | Includes ₹414.9M other income (MTM gains on mutual funds, earnout reversals) |
| ROCE (ex-cash) | 43.7% | vs 44.5% prior quarter |
| Forward Contracts | $500M at ₹93.3/USD | Hedge book as of June 30, 2026 |
| Effective Tax Rate | 22.5% | vs 21.5% prior quarter |
| Dividend | ₹18/share final | Total FY26 dividend ₹40 vs ₹35 in FY25; subject to AGM approval |
Geographic & Segment Commentary
North America: Revenue grew 15.1% YoY; growth partially masked by GCC-related procurement shifts to India. The $650M+ large deal with a US-headquartered tech leader is expected to boost US revenue growth meaningfully in coming quarters; 75-80% of peak revenue expected in Q2 FY27.
Europe: Revenue grew 9.5% YoY, relatively softer vs other geographies; Nagarro acquisition will significantly expand European footprint (expected ~22% combined revenue mix) and nearshore delivery in Romania, Portugal, Hungary, and Poland.
India: Revenue grew 15.8% YoY; growth driven by global customers increasingly routing procurement through India-based GCCs, including carve-outs and greenfield IT setups; seasonal bumps expected, not every quarter.
Rest of World: Revenue grew 117.2% YoY, albeit on a very small base.
Healthcare & Life Sciences: Grew 16.4% YoY, led by payers, CRO/pharma ecosystem, medical devices, and scientific instruments; provider segment relatively tepid; healthy pipeline across segments; full-year growth expected.
BFSI: Grew 16.3% YoY, led by insurance modernization engagements including a $50M+ renewal plus expansion deal to manage 250+ applications.
Software, High-Tech & Emerging: Grew 15.7% YoY; included the $650M+ strategic services agreement and a long-term partnership with a global urban mobility platform provider.
Company-Specific & Strategic Commentary
Nagarro Acquisition: Business combination agreement signed late June 2026; creates AI-led global engineering powerhouse with >$2.9B revenue run-rate and 46,000+ professionals across 40+ countries. Open offer document submitted to BaFin (currently under review), RBI application submitted, FDI and merger control filings in progress. Committed bridge loan in place with long-term financing being secured. Deal expected to close Q4 CY26 or Q1 CY27.
AI Strategy - "Enterprise Context": Strategy built on 3C architecture (Core, Context, Coordination). SAS Va introduced Storyboard and incognito mode for sovereign AI; GenAI Hub expanded to multi-cloud (AWS, Azure, GCP); iAURA added agentic data engineering with GitHub Copilot and Cursor integration. AI IP portfolio expanded to 139 patent filings including 18 new in the quarter.
Measurable AI Outcomes: Kidney care client achieved ~30% lower acute hospital readmissions, 20% higher patient engagement, 15% lower cost of care. PE-owned organizations compressed modernization cycles up to 25% and lifted feature throughput up to 40%. Corporate travel client delivered ~20% procurement savings and 10% operational improvement.
Wage Hikes: Global wage hike rolled out effective July 1, 2026; expected impact of 180-200bps on margins with partial recoupment via operational efficiencies in Q2.
Market Share Gains: Persistent has outperformed listed Indian peers by ~3.5%+ over 16+ quarters; winning disproportionate share through vendor consolidation, proactive pitches, and new outsourcing wins.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| EBIT Margin | 16%-17% aspirational range for FY27 | Management confident of maintaining this range despite wage hike headwinds; operational efficiencies expected to partially offset costs |
| OCF-to-PAT | ~100% (annual) | Management confident of returning to ~100% during the year; current quarter impacted by one-off delays in collections ($23M) and tax refunds ($10M), both received in early Q2 |
| Revenue Growth | Not explicitly guided | Large deal ramp-up: 75-80% of peak revenue in Q2 FY27, full peak by Q3 FY27; 25th consecutive quarter of sequential growth maintained |
| Nagarro Deal Closure | Q4 CY26 or Q1 CY27 | Open offer document under BaFin review, expected publication within a week; four-week acceptance period post-launch; AGM approval results by August 5 |
Risks & Constraints
| Risk | Context |
|---|---|
| Forex Volatility | INR appreciation during Q1 caused ₹1,052.7M forex loss on receivables revaluation and hedging contracts; hedges at ₹93.3/USD with spot at ~₹95 may lead to continued hedging losses if INR appreciates further; quarterly volatility central to PAT swings |
| Utilization Compression | Utilization fell 150bps QoQ to 86.5% due to proactive hiring for large deal ramp-ups; hiring ahead of revenue conversion creates near-term margin pressure (~60bps impact in Q1) |
| Nagarro Integration/Regulatory Risk | BaFin review of open offer, RBI approval, FDI and merger control filings across multiple jurisdictions could delay closure beyond Q1 CY27; financing transition from bridge loan to long-term debt pending |
| Client Concentration | Top customer in high-tech vertical grew strongly this quarter; top 6-10 and 11-20 buckets declined ~4% and ~3.5% QoQ respectively; management attributes to seasonal movements and top-customer growth overlapping high-tech vertical performance |
| AI Pass-Through Cost Structure | AI-related tooling and frontier model costs embedded in service delivery raise purchase costs (₹8M QoQ increase); management frames this as cost of service delivery in outcome-based deals rather than pure pass-through, which could pressure gross margins if not managed |
Q&A Highlights
Geographic Mix & GCC Procurement Shift
- Question: India revenue grew strongly again — is this the same GCC phenomenon as Q4? (Karan Upadhyay)
- Answer: India revenue includes both India-domiciled customers and GCCs of global customers; increasing number of global customers procuring through India-based GCCs is a continuing phenomenon. With Nagarro, Europe exposure will broaden (~22% combined mix) and both US and Europe will grow at significant rates. The $650M large deal will add to US revenue growth next quarter. (Sandeep Kalra)
Large Deal Ramp-Up
- Question: When will the $650M deal ramp up, and will initial phase impact margins? (Ravi Menon)
- Answer: Deal has already partially contributed to revenue in Q1; ~75-80% of peak revenue expected in Q2 FY27 with full peak in subsequent quarter. No significant ramp-up required — teams have been taken over in the interim, with gradual transition to India over time. Manpower additions (1,138 headcount) already support this. (Sandeep Kalra)
Proactive Hiring & Wage Hike Impact
- Question: What is the wage hike impact and software purchase breakdown? (Dipesh Mehta)
- Answer: Wage hike impact expected at 180-200bps for the quarter, with partial recoupment through operational efficiencies in Q2 itself. Software purchases include both internal investments (SASVA, GenAI, iAURA) and external delivery requirements; quarterly spend is not a trend line and will fluctuate. (Vinit Teredesai)
Pass-Through Costs in AI Deals
- Question: What is the pass-through software license component, and are hedge losses expected to continue? (Aditi Patel)
- Answer: Tooling costs are embedded in end-to-end delivery in outcome-based AI deals — including frontier models, cloud spend, and development tools — where Persistent takes accountability for total cost of ownership. Forex losses reflect INR appreciation at quarter-end revaluation plus hedging losses, not just hedge book directional betting; ERP volatility drives the number each quarter. (Sandeep Kalra, Vinit Teredesai)
Market Share vs. Wallet Share
- Question: How much growth comes from winning share from incumbents vs. expanding wallet share? (Aditi Patel)
- Answer: Persistent has outperformed listed Indian peers by ~3.5%+ for 16+ quarters, indicating disproportionate share gains. Wins come from vendor consolidation (vs. larger peers, mid-tiers, US/European providers) and new outsourcing — including the $650M large deal which was a proactive pitch. Combination of both, with an "unfair share" of wins vs. competition. (Sandeep Kalra)
AI Platform Monetization & Deal Wins
- Question: How much do AI platforms contribute to new deal wins, and is there separate license revenue? (Rishi Jhunjhunwala)
- Answer: AI platforms are showcased in pitches across all verticals and service lines, building customer confidence even when specific platforms aren't used. Quantifying AI contribution is meaningless since AI is infused across everything. No separate license revenue model — AI capabilities are embedded in engagement outcomes. (Sandeep Kalra)
Receivables Spike & Cash Flow Normalization
- Question: Is the sharp increase in receivables structural or one-off? (Rishi Jhunjhunwala)
- Answer: One-off — $23M delayed collections collected in the first week of July, $10M tax refunds delayed (with $7M received in Q2's first month). Had these arrived a week earlier, OCF-to-PAT would have looked significantly different. Not structural; TTM OCF-to-PAT of 76.2% provides normalized perspective, expected to normalize from Q2. (Sandeep Kalra, Vinit Teredesai)
Healthcare Vertical Outlook
- Question: How is the healthcare vertical positioned given industry-wide demand shifts? (Vibhor Singhal)
- Answer: Healthcare has grown well over several years; pipeline is strong across payers, CRO/pharma, scientific instruments, medical devices. Provider segment is relatively tepid but overall healthy full-year growth expected. (Sandeep Kalra)
Key Takeaway
Persistent delivered its 25th consecutive quarter of sequential revenue growth in Q1 FY27, with USD revenue of $452.4M (+3.8% QoQ, +16.1% YoY) and EBIT margin of 16.0% (within the 16-17% aspirational band, though down 30bps QoQ on utilization and AI tooling costs). The quarter was marked by record TCV bookings of $1.146B, driven by a $650M+ strategic services agreement with a US global tech leader, with 75-80% of peak revenue expected as early as Q2 FY27. PAT declined 8.7% QoQ on a ₹1,052.7M forex loss, though adjusted OCF-to-PAT would have been 83.2% absent one-off collection and tax refund delays. The Nagarro acquisition (deal closure expected Q4 CY26/Q1 CY27) positions the combined entity with >$2.9B revenue run-rate and 46,000+ professionals, expanding Europe mix to ~22% and adding industrial/consumer vertical scale. AI investments continue to drive measurable client outcomes (30% lower readmissions in healthcare, 25% faster modernization cycles), supported by 139 patent filings. Key watch items include utilization recovery from proactive hiring, forex volatility impact on reported PAT, and integration execution risk on Nagarro closure and regulatory approvals.